Alzheimer's & dementia (Amsterdam, Netherlands) · 2026
Harmonizing biofluid specimen collection and biomarker quantification in Diverse Vascular Contributions to Cognitive Impairment and Dementia (DVCID) study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhou Sitong, Conston Jacob, Suthprasertporn Nopparat, Denis-Romero Ramses, Lucente Jacopo Di, White Jeannine L, Mielke Michelle M, Harvey Danielle, Rajan Kumar B, Johnson David K, Fornage Myriam, DeCarli Charles, Hinman Jason D, Jin Lee-Way, DVCID Study Investigators
Аннотация
INTRODUCTION: Multicenter clinical studies inherently face challenges in maintaining consistency across sites. Here we share the design and implementation of standard operating procedures (SOPs) for the Diverse Vascular Contributions to Cognitive Impairment and Dementia (DVCID) study.
METHODS: The Repository Core implements harmonized protocols for biospecimen collection and preparation. Pre-, intra-, and post-analytical factors influencing sample integrity and data reliability are addressed. Stringent measures are applied to obtain reproducible biomarker data.
RESULTS: Rigorous post-analytical quality control ensures assay variabilities within acceptable limits. Interim analyses, presented as proof of concept, show differences in selected plasma biomarkers across sex and race/ethnicity after covariate adjustment. These efforts establish a strong foundation for the high-quality data generated in DVCID, supporting reliability of downstream analyses.
DISCUSSION: This work demonstrates a standardized framework to enhance data comparability, aiming to inform and facilitate future multicenter biomarker studies. Interim findings also highlight the potential need for ethnoracially tailored cut-offs when interpreting blood-based biomarker data.
METHODS: The Repository Core implements harmonized protocols for biospecimen collection and preparation. Pre-, intra-, and post-analytical factors influencing sample integrity and data reliability are addressed. Stringent measures are applied to obtain reproducible biomarker data.
RESULTS: Rigorous post-analytical quality control ensures assay variabilities within acceptable limits. Interim analyses, presented as proof of concept, show differences in selected plasma biomarkers across sex and race/ethnicity after covariate adjustment. These efforts establish a strong foundation for the high-quality data generated in DVCID, supporting reliability of downstream analyses.
DISCUSSION: This work demonstrates a standardized framework to enhance data comparability, aiming to inform and facilitate future multicenter biomarker studies. Interim findings also highlight the potential need for ethnoracially tailored cut-offs when interpreting blood-based biomarker data.